In fact, it was revealed that the upregulated expression of TRPA1 observed in breast cancer cells enhances resistance to ROS by triggering Ca2+-dependent signaling pathways that inhibit apoptosis. The gene discussed is TRPA1; the disease is breast carcinoma.